Details for 2008771026

Up to date per 01.04.2026

Actions

Title / Product Name

NATALIZUMAB-ANTIKÖRPER-FORMULIERUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2008771026

EP Publication Number

2170390

E-Number

1061294

Language

PCT Number

US08066928

Publication Date

07.04.2010 A

07.11.2018 B1

Registration Date

07.11.2018

AT Publication Date

15.11.2018

Application Date

13.06.2008

Registration Number

Priorities

14.06.2007

944076 P

IPC

A61K 39/395 20060101AFI20180404BHEP

Maximum Duration of Protection

13.06.2028

Owner

Biogen MA Inc.225 Binney Street Cambridge, MA 02142US

Representative

No representatives present

Inventor

MALONEY, Kevin10 Adella Drive Nashua, NH 03063US

Information about Fees